Dana, Nasim, Golnaz Vaseghi, and shaghayegh haghjooy javanmard. “PPAR γ Agonist, Pioglitazone, Suppresses Melanoma Cancer in Mice by Inhibiting TLR4 Signaling”. Journal of Pharmacy & Pharmaceutical Sciences 22, no. 1 (September 10, 2019): 418–423. Accessed November 12, 2024. https://journals.library.ualberta.ca/jpps/index.php/JPPS/article/view/30626.